Featured image: [NASA Langley’s Freefly Alta X quadcopter on the CERTAIN test range; credit: NASA Langley / David C. Bowman]
On June 5, 2026, researchers at NASA’s Langley Research Center in Hampton, Virginia, flew human kidneys by drone beyond visual line of sight for the first time, a milestone that could reshape the logistics of organ transplantation on Earth and, eventually, medical supply delivery on the Moon and Mars.
The test used a Freefly Alta X quadcopter, one of the largest drones in NASA Langley’s inventory, capable of carrying payloads up to 15 kilograms (33 pounds). Two human kidneys donated for research were placed in standard organ transport containers on preservation pumps and flown in loops around Langley’s City Environment Range Testing for Autonomous Integrated Navigation, or CERTAIN, a test range designed to certify beyond-visual-line-of-sight (BVLOS) drone operations in complex environments.
Each flight covered roughly 12 kilometers (7.5 miles) and lasted approximately 15 minutes at a peak altitude of 76 meters (250 feet). The pilot was stationed one mile away in a control room, monitoring via additional radio links, with no human spotters on rooftops along the route. That distinction separates this test from the first organ drone delivery in 2019, when the University of Maryland flew a kidney 4.5 kilometers (2.8 miles) to a Baltimore hospital, a flight that required people stationed on rooftops as visual observers.
“You get a sense of the potential impact,” said John Koelling, director of the Aeronautics Research Directorate at NASA Langley. “This is a chance to apply NASA Langley technology to a real-world problem that can save people’s lives who are waiting for transplants.”
Beyond line of sight
The ability to fly drones beyond the pilot’s direct visual range is the critical enabler for practical organ delivery. Routine BVLOS operations would allow drones to fly between hospitals across cities without requiring spotters on every rooftop, a system that Jim Burgess, the flight test team lead at Langley, noted is “not necessarily scalable.”
The kidneys were biopsied and placed on preservation pumps before and after each flight, and researchers monitored temperature, pressure, altitude, and vibration throughout. Preliminary results showed no evidence that the drone flights negatively affected the organs.
The test was conducted under NASA Langley’s existing BVLOS Certificate of Authorization from the Federal Aviation Administration, with procedural deconfliction against Langley Air Force Base’s Class D airspace and manned aircraft operating above 270 meters (900 feet).
A crisis of logistics
More than 100,000 people in the United States are currently waiting for organ transplants, with 13 people dying each day before an organ becomes available. Organs are currently transported by ground courier, commercial air, or chartered aircraft, all escorted by certified couriers with tracking devices. But each mode has limitations: ground transport gets caught in traffic, commercial flights suffer delays and missed connections, and charters are expensive.
Drones offer a potential solution for the so-called last mile: the critical segment between a donor hospital and an airport, or between an airport and a transplant center. UNOS, the nonprofit that manages the U.S. organ transplant system, co-designed the study and envisions drones flying up to 24 kilometers (15 miles) between hospitals.
“With more than 100,000 people currently waiting for a lifesaving transplant nationwide, innovation in organ transportation is essential,” said Mark Johnson, interim CEO of UNOS. “This successful collaboration represents an important step toward making organ transportation safer, faster and more efficient.”
Space connections
The same autonomous navigation and environmental monitoring technologies NASA is testing for organ delivery have direct applications beyond Earth. NASA’s MoonFall mission, announced in March 2026, plans to send four propulsive drones to the lunar south pole by 2028 to scout potential Artemis landing sites and map permanently shadowed craters. The Dragonfly mission to Saturn’s moon Titan, launching in 2028 and arriving in 2034, will fly an eight-rotor nuclear-powered quadcopter through a thick nitrogen atmosphere in search of prebiotic chemistry.
On a future lunar outpost or Mars base, the ability to fly medical supplies between habitats or from a landed spacecraft to a pressurized rover would require exactly the kind of real-time monitoring of temperature, pressure, and vibration that the Langley team tested with the kidney transport.
“The idea that something of worldwide benefit could be created in our own backyard is pretty exciting,” said Koelling, who noted that Hampton Roads was chosen as the test site precisely because it concentrates every challenge drone operators might face: military bases, nuclear plants, dense urban areas, and a major seaport.
What comes next
The partnership between NASA Langley, UNOS, and LifeNet Health is governed by a Space Act Agreement signed in April 2026. While further testing is needed before drone organ delivery becomes routine, Koelling framed the June 5 flight as a proof of concept. “This is sort of proof of concept for us,” he said. “The technology to do this is pretty much largely in place.”
The broader regulatory framework for routine BVLOS drone operations in the United States, FAA Part 108, missed its February 2026 deadline due to airspace conflicts with crewed aircraft. But as Langley’s test demonstrated, the biology is proven and the technology is ready. What remains is the infrastructure to let it fly at scale.